- Home
- IMMP vs FSBW Comparison
IMMP vs FSBW Comparison
Compare IMMP & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- FSBW
- Stock Information
- Founded
- IMMP 1987
- FSBW 1936
- Country
- IMMP Australia
- FSBW United States
- Employees
- IMMP N/A
- FSBW N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- FSBW Banks
- Sector
- IMMP Health Care
- FSBW Finance
- Exchange
- IMMP Nasdaq
- FSBW Nasdaq
- Market Cap
- IMMP 304.0M
- FSBW 318.4M
- IPO Year
- IMMP N/A
- FSBW 2012
- Fundamental
- Price
- IMMP $1.81
- FSBW $36.46
- Analyst Decision
- IMMP Buy
- FSBW Hold
- Analyst Count
- IMMP 2
- FSBW 1
- Target Price
- IMMP $8.50
- FSBW $44.00
- AVG Volume (30 Days)
- IMMP 82.5K
- FSBW 11.8K
- Earning Date
- IMMP 03-25-2025
- FSBW 04-23-2025
- Dividend Yield
- IMMP N/A
- FSBW 2.94%
- EPS Growth
- IMMP N/A
- FSBW N/A
- EPS
- IMMP N/A
- FSBW 4.36
- Revenue
- IMMP $3,019,249.00
- FSBW $139,150,000.00
- Revenue This Year
- IMMP N/A
- FSBW $9.22
- Revenue Next Year
- IMMP $20.28
- FSBW $6.31
- P/E Ratio
- IMMP N/A
- FSBW $8.43
- Revenue Growth
- IMMP 24.11
- FSBW 0.09
- 52 Week Low
- IMMP $1.65
- FSBW $30.64
- 52 Week High
- IMMP $3.34
- FSBW $49.15
- Technical
- Relative Strength Index (RSI)
- IMMP 41.69
- FSBW 38.22
- Support Level
- IMMP $1.65
- FSBW $35.46
- Resistance Level
- IMMP $1.88
- FSBW $38.01
- Average True Range (ATR)
- IMMP 0.10
- FSBW 0.91
- MACD
- IMMP -0.01
- FSBW -0.10
- Stochastic Oscillator
- IMMP 41.94
- FSBW 25.32
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About FSBW FS Bancorp Inc.
FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.